-
-
-
-
-
-
-
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
-
-
-
-
-
-
-
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
-
-
-
-
-
-
-
GenScript Biotech Corporation Reports FY 2024 Results
-
-
-
-
-
-
-
Scotiabank Reiterates Sector Outperform Rating on Legend Biotech Corp. (LEGN)
-
-
-
-
-
-
-
Legend Biotech Corp. (LEGN) PT Raised to $86 at RBC Capital
-
-
-
-
-
-
-
Legend Biotech (LEGN) Tops Q3 EPS by 14c
-
1,216,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

